Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics
Open Access
- 15 June 2001
- journal article
- review article
- Published by Hindawi Limited in Journal of Clinical Pharmacy & Therapeutics
- Vol. 26 (3) , 159-169
- https://doi.org/10.1046/j.1365-2710.2001.00338.x
Abstract
Itraconazole is a triazole antifungal agent with a broad spectrum of activity. It is well tolerated and highly efficacious, particularly because its main metabolite, hydroxy‐itraconazole, also has co...Keywords
This publication has 52 references indexed in Scilit:
- Fluconazole sensitivities of Candida species isolated from the mouths of terminally ill cancer patientsAmerican Journal of Hospice and Palliative Medicine®, 1998
- Pharmacokinetics of itraconazole oral solution in allogeneic bone marrow transplant patients receiving total body irradiationBone Marrow Transplantation, 1998
- Optimisation of Itraconazole Therapy Using Target Drug ConcentrationsClinical Pharmacokinetics, 1998
- Therapy of deep fungal infection in haematological malignancy. Working Party of the British Society for Antimicrobial ChemotherapyJournal of Antimicrobial Chemotherapy, 1997
- Itraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immunodeficiency syndrome patients with candidosis.Journal of Clinical Pathology, 1997
- Itraconazole Pulse Therapy for OnychomycosisJournal of Pharmacy Practice, 1997
- Safety and pharmacokinetics of fluconazole in children with neoplastic diseasesThe Journal of Pediatrics, 1992
- Itraconazole penetrates the nail via the nail matrix and the nail bed-an investigation in onychomycosisClinical and Experimental Dermatology, 1991
- ItraconazoleDrugs, 1989
- Pharmacokinetic profile of orally administered itraconazole in human skinJournal of the American Academy of Dermatology, 1988